Recruiting Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved. NCT07276542 Conditions Nervous System Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, +9 more Locations Shamynds — Sacramento, California, United States Ketamine Research Foundation — San Anselmo, California, United States Mystic Health — Santa Monica, California, United States Lisa Feierman MD — Albuquerque, New Mexico, United States View Trial Details
Active, Not Recruiting VR to Evaluate Phantom Limb Pain NCT05915065 Conditions Amputation, Lower Limb Amputation Above Knee (Injury), Lower Limb Amputation Below Knee (Injury), +24 more Locations Shirley Ryan AbilityLab — Chicago, Illinois, United States View Trial Details
